Fundraising Fox

Bruce Cohen

Investor

Venture Partner at Xeraya Capital

About

Bruce Cohen joined Xeraya Capital in January 2016, bringing over 30 years of management, marketing, and business development experience in life sciences and high technology in the United States. He was the founding President and CEO of three early-stage biotech companies — Acacia Biosciences, Cellerant Therapeutics, and VitaPath Genetics — and previously served as CFO at GeneSoft and held roles at SEQUUS Pharmaceuticals and Baxter International. He holds a BA and MA from Tufts University and an MBA from Harvard Business School.

Invests in

BiotechDigital HealthMedical Devices

Colleagues at Xeraya Capital

Frequently asked questions

Who is Bruce Cohen?
Bruce Cohen joined Xeraya Capital in January 2016, bringing over 30 years of management, marketing, and business development experience in life sciences and high technology in the United States. He was the founding President and CEO of three early-stage biotech companies — Acacia Biosciences, Cellerant Therapeutics, and VitaPath Genetics — and previously served as CFO at GeneSoft and held roles at SEQUUS Pharmaceuticals and Baxter International. He holds a BA and MA from Tufts University and an MBA from Harvard Business School.
Where does Bruce Cohen work?
Bruce Cohen is Venture Partner at Xeraya Capital.
What does Bruce Cohen invest in?
Bruce Cohen invests in Biotech, Digital Health, Medical Devices.